Date: 2025/06/05 - 00:00
An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered an anti-inflammatory diet had longer overall survival rates than those who followed a pro-inflammatory diet.
Date: 2025/06/04 - 00:32
Researchers report that a three-year exercise program helped improve survival rates for people who have been treated for colon cancer. The findings could be helpful for doctors recommending exercise as part of a post-cancer regimen.
Date: 2025/05/19 - 22:32
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.
Date: 2025/05/15 - 23:32
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.